Ocular Therapeutix, Inc
OCUL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001393434
In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Ocular Therapeutix, Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 149 | 1 | 141 | −7 |
| Shares | 48.4M | 2.00K | 44.5M | −3.83M (−7.9%) |
| Value | $685.8M | $28.0K | $445.7M | −$240.1M (−35.0%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Ocular Therapeutix, Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cetera Investment Advisers | 432,100 | $4.32M | 0.07% |
| Healthcare of Ontario Pension Plan Trust Fund | 181,600 | $1.82M | 0.00% |
| Tudor Investment Corp Et Al | 94,712 | $947.0K | 0.02% |
| Cetera Advisors LLC | 86,916 | $869.0K | 0.02% |
| Voloridge Investment Management, LLC | 67,506 | $675.0K | 0.00% |
| SG Americas Securities, LLC | 39,101 | $391.0K | 0.00% |
| Ergoteles LLC | 36,107 | $361.0K | 0.01% |
| Marshall Wace North America L.P. | 15,971 | $160.0K | 0.00% |
| Northeast Financial Consultants Inc | 14,015 | $140.0K | 0.01% |
| CSS LLC | 10,570 | $106.0K | 0.01% |
| Virginia Retirement Systems Et Al | 10,400 | $104.0K | 0.00% |
| Teacher Retirement System of Texas | 10,314 | $103.0K | 0.00% |
| Versor Investments LP | 10,300 | $103.0K | 0.00% |
| Algert Global LLC | 10,100 | $101.0K | 0.01% |
| Eagle Bay Advisors LLC | 800 | $8.00K | 0.00% |
| Dark Forest Capital Management LP | 2,187 | – | – |
Sold out (23)
Institutions that held Ocular Therapeutix, Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Great Point Partners LLC | 919,887 | $13.0M |
| Susquehanna International Group, LLP | 247,270 | $3.51M |
| Lisanti Capital Growth, LLC | 179,700 | $2.55M |
| Eversept Partners, LP | 150,000 | $2.13M |
| Fred Alger Management, LLC | 67,584 | $958.0K |
| Kiwi Wealth Investments Limited Partnership | 54,741 | $776.0K |
| AlphaCrest Capital Management LLC | 53,700 | $761.0K |
| XTX Topco Ltd | 23,121 | $328.0K |
| Belvedere Trading LLC | 23,347 | $289.0K |
| Tiff Advisory Services Inc | 14,224 | $276.0K |
| Bridgefront Capital, LLC | 17,141 | $243.0K |
| Engineers Gate Manager LP | 13,816 | $196.0K |
| Twinbeech Capital LP | 13,311 | $189.0K |
| Virtu Financial LLC | 12,641 | $179.0K |
| Ameriprise Financial Inc | 11,413 | $162.0K |
| Walleye Trading LLC | 5,657 | $80.0K |
| Quantbot Technologies LP | 3,151 | $44.0K |
| Leonteq Securities AG | 2,000 | $28.4K |
| Panagora Asset Management Inc | 1,378 | $20.0K |
| Exane Derivatives | 1,496 | $19.3K |
| Point72 Hong Kong Ltd | 1,326 | $19.0K |
| Huntington National Bank | 400 | $6.00K |
| Advisory Services Network, LLC | 250 | $4.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Ocular Therapeutix, Inc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| CWM, LLC | 2,000 | $28.0K |